Laura Lovett

Treating the opioid epidemic has challenged researchers and providers for years.

Patient-provider communication platform Luma Health has just announced that it landed $6.

In the past checking your blood pressure generally meant a trip to the doctor's office—or at least a pharmacy.

Eye telemedicine company Simple Contacts announced it raked in $16 million in Series B funding at the end of last week.

The British government is now turning to artificial intelligence as an avenue for early cancer and chronic disease detection.

This morning, the employee wellness and health engagement platforms Virgin Pulse and RedBrick Health announced that they are merging under the Virgin Pulse name.

Yesterday, startup LifePlus exited stealth mode to reveal what it claims to be the first noninvasive continuous blood glucose monitoring multi-sensor wearable, called LifeLeaf.

Head and neck cancer patients who were given smartphone and sensor technology as a way to remotely monitor their symptoms reported less severe symptoms from their cancer and treatment than their counterparts who did receive the technology, according to a recent study presented at the American Society of Clinical Oncology annual meeting.

This morning Shanghai-based insurtech company CareVoice launched what it claims is the first AI voice-based virtual health assistant for insurers and employers in Greater China.

DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers.